• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯放疗或联合全身化疗治疗口咽鳞状细胞癌患者的预后因素分析

Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy.

作者信息

Pedruzzi Paola A G, Kowalski Luiz P, Nishimoto Ines N, Oliveira Benedito V, Tironi Fabio, Ramos Gyl H A

机构信息

Department of Head and Neck Surgery, Erasto Gaertner Hospital, Curitiba, Brazil.

出版信息

Arch Otolaryngol Head Neck Surg. 2008 Nov;134(11):1196-204. doi: 10.1001/archotol.134.11.1196.

DOI:10.1001/archotol.134.11.1196
PMID:19015451
Abstract

OBJECTIVE

To assess the prognostic significance of several factors in oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with chemotherapy.

DESIGN

Retrospective study.

SETTING

Erasto Gaertner Hospital, Curitiba, Brazil, and A. C. Camargo Hospital, São Paulo, Brazil.

PATIENTS

A total of 361 patients treated for squamous cell carcinoma from January 1, 1990, to December 31, 2001.

INTERVENTIONS

Radiotherapy alone or with chemotherapy.

MAIN OUTCOME MEASURES

Disease-free survival, overall survival, and treatment response.

RESULTS

Most tumors were located at the tonsil (46.8%) or base of the tongue (28.0%) and were at clinical stage III or IV (92.8%). Treatment response was associated with Zubrod scale score, weight loss, number of comorbidities, symptom-severity and Piccirillo stages, hemoglobin level, tumor site, macroscopic appearance of the tumor, and clinical stage. The 5-year overall survival rate was 17.6% and disease-free survival rate was 16.2%. The significant prognostic variables were age; Zubrod scale score; weight loss; comorbidities; Berg, Piccirillo, and symptom-severity staging; involvement of adjacent soft-tissue areas and bone; lymph node mobility; clinical stage; and radiotherapy doses. The multivariate analysis showed Zubrod scale score, symptom-severity staging system, Berg staging system, comorbidities, and radiotherapy dose as independent prognostic factors.

CONCLUSION

A combination of clinical factors, such as symptoms, patients' general status, weight loss, and comorbidities, leads to a relevant stage of clinical severity that can be associated with the TNM stage as predictors of survival in oropharyngeal carcinoma.

摘要

目的

评估单纯放疗或放化疗联合治疗口咽鳞状细胞癌时,多种因素的预后意义。

设计

回顾性研究。

地点

巴西库里蒂巴的埃拉斯托·盖特纳医院以及巴西圣保罗的A.C.卡马戈医院。

患者

1990年1月1日至2001年12月31日期间共361例接受鳞状细胞癌治疗的患者。

干预措施

单纯放疗或联合化疗。

主要观察指标

无病生存期、总生存期和治疗反应。

结果

大多数肿瘤位于扁桃体(46.8%)或舌根(28.0%),临床分期为III期或IV期(92.8%)。治疗反应与Zubrod评分、体重减轻、合并症数量、症状严重程度和Piccirillo分期、血红蛋白水平、肿瘤部位、肿瘤大体外观及临床分期相关。5年总生存率为17.6%,无病生存率为16.2%。显著的预后变量包括年龄;Zubrod评分;体重减轻;合并症;Berg、Piccirillo和症状严重程度分期;相邻软组织区域和骨骼受累情况;淋巴结活动度;临床分期;以及放疗剂量。多因素分析显示Zubrod评分、症状严重程度分期系统、Berg分期系统、合并症和放疗剂量为独立的预后因素。

结论

症状、患者一般状况、体重减轻和合并症等临床因素的综合作用导致了一个相关的临床严重程度阶段,该阶段可与TNM分期相关联,作为口咽癌生存的预测指标。

相似文献

1
Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy.单纯放疗或联合全身化疗治疗口咽鳞状细胞癌患者的预后因素分析
Arch Otolaryngol Head Neck Surg. 2008 Nov;134(11):1196-204. doi: 10.1001/archotol.134.11.1196.
2
Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.口咽癌的调强放射治疗:肿瘤体积的影响
Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):43-50. doi: 10.1016/j.ijrobp.2003.08.004.
3
Prognostic factors in oropharyngeal cancer--analysis of 627 cases receiving definitive radiotherapy.口咽癌的预后因素——627 例接受根治性放疗的病例分析。
Acta Oncol. 2009;48(7):1026-33. doi: 10.1080/02841860902845839.
4
Combined surgery and postoperative radiotherapy for oropharyngeal squamous cell carcinoma in Korea: analysis of 110 cases.韩国口咽鳞状细胞癌的联合手术与术后放疗:110例分析
Int J Oral Maxillofac Surg. 2008 Dec;37(12):1099-105. doi: 10.1016/j.ijom.2008.07.002. Epub 2008 Aug 22.
5
Clinicopathological presentation of tongue cancers and early cancer treatment.舌癌的临床病理表现及早期癌症治疗
J Coll Physicians Surg Pak. 2006 Mar;16(3):179-82.
6
Squamous cell carcinoma of the oral tongue: a 25-year, single institution experience.口腔舌鳞状细胞癌:一项基于单机构的25年经验研究。
J Laryngol Otol. 2009 Jan;123(1):114-20. doi: 10.1017/S0022215108003186. Epub 2008 Jun 30.
7
Combined-modality treatment for advanced oral tongue squamous cell carcinoma.晚期口腔舌鳞状细胞癌的综合治疗
Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):453-61. doi: 10.1016/j.ijrobp.2006.06.026.
8
Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma.法国头颈肿瘤与放射治疗组94-01随机试验的最终结果:比较晚期口咽癌单纯放疗与同步放化疗的疗效。
J Clin Oncol. 2004 Jan 1;22(1):69-76. doi: 10.1200/JCO.2004.08.021. Epub 2003 Dec 2.
9
[Carcinoma of the oropharynx extended to the base of the tongue: radiosurgical treatment with intraoperative radiotherapy].[口咽癌累及舌根:术中放疗的放射外科治疗]
Bull Cancer Radiother. 1996;83(2):79-85.
10
Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach.对淋巴结阳性扁桃体癌采用同侧颈部放疗时对侧颈部无局部和区域失败情况:一种前瞻性管理方法的结果
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1365-70. doi: 10.1016/j.ijrobp.2008.10.023. Epub 2009 Jan 23.

引用本文的文献

1
Quantitative magnetic resonance imaging responses in head and neck cancer patients treated with magnetic resonance-guided hypofractionated radiation therapy.接受磁共振引导下大分割放射治疗的头颈癌患者的定量磁共振成像反应
Phys Imaging Radiat Oncol. 2025 Jan 2;33:100693. doi: 10.1016/j.phro.2024.100693. eCollection 2025 Jan.
2
Epigenetic downregulation of the proapoptotic gene in oral squamous cell carcinoma.口腔鳞状细胞癌中促凋亡基因的表观遗传下调。
Mol Med Rep. 2025 Mar;31(3). doi: 10.3892/mmr.2024.13421. Epub 2024 Dec 20.
3
Acute Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT.
癌症治疗对头颈癌患者的急性影响:FIT4TREATMENT。
Cancers (Basel). 2022 May 30;14(11):2698. doi: 10.3390/cancers14112698.
4
Palbociclib Renders Human Papilloma Virus-Negative Head and Neck Squamous Cell Carcinoma Vulnerable to the Senolytic Agent Navitoclax.帕博西尼使人乳头瘤病毒阴性的头颈部鳞状细胞癌对衰老细胞清除剂纳维托昔单抗敏感。
Mol Cancer Res. 2021 May;19(5):862-873. doi: 10.1158/1541-7786.MCR-20-0915. Epub 2021 Jan 25.
5
Clinical predictors for reactive tube feeding in patients with advanced oropharynx cancer receiving radiotherapy ± chemotherapy.接受放疗±化疗的晚期口咽癌患者反应性管饲的临床预测因素
Eur Arch Otorhinolaryngol. 2017 Oct;274(10):3741-3749. doi: 10.1007/s00405-017-4681-x. Epub 2017 Jul 26.
6
Weight and body mass index in relation to irradiated volume and to overall survival in patients with oropharyngeal cancer: a retrospective cohort study.体重和身体质量指数与口咽癌患者的照射体积和总生存率的关系:一项回顾性队列研究。
Radiat Oncol. 2014 Jul 22;9:160. doi: 10.1186/1748-717X-9-160.
7
Patients from the Oral Oncology Center, UNESP, Araçatuba with an indication for prosthesis.来自巴西圣保罗州立大学牙科学院阿拉萨图巴分校口腔肿瘤中心且有假体植入指征的患者。
Mol Clin Oncol. 2013 Jul;1(4):733-736. doi: 10.3892/mco.2013.105. Epub 2013 Apr 17.
8
Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy.对于接受放疗的头颈部癌症患者,体重急剧下降是疾病特异性生存的一个主要预后指标。
Br J Cancer. 2013 Sep 3;109(5):1093-9. doi: 10.1038/bjc.2013.458. Epub 2013 Aug 8.
9
Head and neck squamous carcinomas with exophytic and endophytic type of growth have the same prognosis after surgery and adjuvant radiotherapy.头颈部外生性和内生型生长的鳞状细胞癌在手术后和辅助放疗后的预后相同。
Eur Arch Otorhinolaryngol. 2013 Mar;270(3):1105-14. doi: 10.1007/s00405-012-2117-1. Epub 2012 Aug 4.
10
Nutritional surveillance and weight loss in head and neck cancer patients.头颈部癌症患者的营养监测和体重减轻。
Support Care Cancer. 2012 Apr;20(4):757-65. doi: 10.1007/s00520-011-1146-4. Epub 2011 Apr 19.